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Abstract
Background: Various human diseases have oxidative stress as one of their component. Many
herbs have been reported to exhibit properties that combat oxidative stress through their active
constituents such as flavonoids, tannins, phenolic compounds etc. Cytisus scoparius (CS) Link,
(Family: Leguminosae), also called Sarothamnus scoparius, has been shown in invitro experiments to
be endowed with anti-diabetic, hypnotic and sedative and antioxidant activity. Therefore this study
was carried out to evaluate CS for its anxiolytic, antidepressant and anti-oxidant activity in stressed
rats.
Methods: 60% methanolic extract of CS was quantified for phenolic content by Folin-Ciocalteau's
method. Chronic unpredictable mild stress (CMS) was employed to induce stress in rats. CS (125
and 250 mg/kg, p.o) and diazepam (DZM) (2 mg/kg, p.o) was administered during the 21 day stress
exposure period. Anxiolytic and antidepressant activities of CS were assessed in open field
exploratory and behavioural despair paradigms, respectively. Plasma glucose and total lipids;
endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT); non-
enzymic-ascorbic acid and thiobarbituric acid reactive substances (TBARS) levels were measured
in brain, kidneys and adrenals using standard protocols to assess the effect of CS.
Results:  Total phenolic content of CS was found to be 8.54 ± 0.16% w/w. CMS produced
anxiogenic and depressive behaviour in experimental rats with metabolic disturbance. Significant
decrease in SOD, CAT levels and increase in lipid peroxidation level was observed in stressed rats.
CS administration for 21 days during stress exposure significantly increased the ambulatory
behaviour and decreased the freezing time in open field behaviour. In behavioural despair test no
significant alteration in the immobility period was observed. CS also improved SOD, CAT, and
ascorbic acid level and controlled the lipid peroxidation in different tissues.
Conclusion: CS possesses anti-stress and moderate anxiolytic activity which may be due, in part,
to its antioxidant effect that might warrant further studies.
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Background
According to the World Health report, approximately 450
million people suffer from a mental or behavioural disor-
der [1]. This amounts to 12.3% of the global burden of
disease, and predicted to raise upto 15% by 2020 [2].
Stress is a state of threatened homeostasis provoked by
psychological, physiological or environmental stressors
[3]. Stressor is a stimulus either internal or external, which
activates the hypothalamic pituitary adrenal axis and the
sympathetic nervous system resulting in a physiological
change [4]. Stressful conditions can precipitate anxiety
and depression, which can lead to excessive production of
free radicals which in turn results in oxidative stress, an
imbalance in the oxidant/antioxidant system. Currently
different therapeutic regimens are employed to treat anxi-
ety and depressive disorders; but their clinical uses are
limited by their side effects such as psychomotor impair-
ment, potentiation of other central depressant drugs and
dependence liability. In the search for new therapeutic
products for the treatment of neurological disorders –
medicinal plant research has also contributed signifi-
cantly by demonstrating pharmacological effectiveness of
different herbs in various animal models [5].
Cytisus scoparius Link., (Family: Leguminosae) also called
as Sarothamnus scoparius is a popular herb in Ayurveda. CS
species is commonly available in Nilgiris biosphere of
Tamil Nadu, India. Ethnomedical information states that
this herb is used as diuretics, hypnotics, sedative [6].
Experimental reports indicated that CS possessed anti-dia-
betic [7], hepatoprotective [8], antispasmodic, hypoten-
sive and estrogenic effect [9]. The pharmacological activity
of CS was attributed due to the chemical constituents 6-O-
acetyl scoparian [10], flavonals like rutin, quercitin,
isorhamnetin, quercitrin and kaempferol [11] and isofla-
vones namely genistein and sarothamnoside [12]. Alka-
loids like spartein, sarothamine and lupamine were also
reported to be present in CS [13].
Conditions of stress precipitated glucose intolerance,
immuno-suppression, behavioural depression, cognitive
deficits and male sexual dysfunction in rats. Administra-
tion of Withania somnifera during the stress period allevi-
ated these alterations. It was postulated that, at least in
some instances, the beneficial effect of Withania somnifera
was due to its anti-oxidative stress action [14,15]. Like
wise the antioxidant property of CS in in vitro and in vivo
models was attributed to its phenolic content [16,17].
This formed the basis for the present investigation which
aimed to investigate the potential role of CS in reversing
the behavioural and biochemical alterations in CMS rats.
Methods
Chemicals
All chemicals and solvents used were of analytical grade
and were obtained from SISCO Research Laboratories,
Mumbai, India.
Plant material
CS collected from Nilgiris Biosphere, Tamil Nadu, India
was authenticated by Botanist, Dr. S. Rajan, Survey of
Indian medicinal plants, Govt. Arts College, Ootaca-
mund. For future references voucher specimen of CS was
preserved as herbarium in department of Pharmacognosy,
JSS College of Pharmacy, Ooty, India.
Preparation of extract
Shade dried aerial parts of CS was coarsely powdered and
macerated with 60% methanol at room temperature for
72 h. The filtrate was dried in a rotary vacuum evaporator
under reduced pressure at 50°C. The extract was stored in
desiccator for future use.
Estimation of total phenolic content
Total phenolic content of CS was estimated by employing
Follin-Ciocalteau method [18] as stated here. Extract solu-
tion of 0.1 ml CS (containing 1000 µg) was taken in a vol-
umetric flask and diluted with distilled water to 46 ml.
About 1 ml of Folin – Ciocalteu reagent was added to the
contents of the flask and mixed thoroughly. After 3 min,
3 ml of Na2CO3 (2%) was added and the mixture was
allowed to stand for 2 h with intermittent shaking. The
absorbance was measured at 760 nm. Phenolic content
was calculated using pyrocatechol as standard.
Animals
Thirty adult male Wistar strain rats (160–175 g) were pro-
cured from the central animal facility and divided into five
groups of six animals each. They were housed in colony
cages at an ambient temperature of 25 ± 2°C and 40–65%
relative humidity, with 12-h light: dark cycle. The animals
had free access to standard pellet chow and drinking
water. Institutional Animal Ethics Committee (IAEC)
approved the study and all the experiments were carried
out by following the guidelines of CPCSEA, India.
Groups and treatment
Four groups of rats were exposed to CMS and received
p.o.: vehicle (0.3% Carboxy methyl cellulose CMC, 1 ml/
kg), diazepam (DZM, 2 mg/kg), CS (125 and 250 mg/kg)
respectively. Drugs (CS and DZM) were prepared as fine
suspension in 0.3% CMC and administered one hour
before the stress exposure for 21 days (Figure 1).
Induction of stress
Stress was induced by employing the Chronic Unpredict-
able Mild Stress (CMS) protocol. It was based on theBMC Complementary and Alternative Medicine 2008, 8:15 http://www.biomedcentral.com/1472-6882/8/15
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modus operandi originally used by Pal and Dandiya
(1993) [19] with minor modifications. Each stress regi-
men was carried out for 2 periods with the following stres-
sors: food deprivation for 24 h, day-night reversal, soiled
bedding (~150 ml water per cage) for 22 h, cage tilting
(~45 degree inclined) for 22 h, crowded housing (10 ani-
mals per cage) for 12 h, exposure to a novel odor (house-
hold air freshener) for 12 h, restraint stress for 20 min,
cold stress 4–8°C and heat stress 38–39°C for 20 min and
intermittent white noise (80 dB) for 5 h for 3 periods.
Behavioural analysis
Open field exploratory behaviour test
Open field test was used to study the exploratory and anx-
iety behaviour of rats [20]. The open field apparatus con-
sisted of a square arena 60 × 60 cm with 40 cm high wall.
The entire apparatus was painted black except for 6 mm
white lines that divided the floor into 16 equal size
squares. The apparatus was illuminated with a low inten-
sity diffuse light (45 W) situated 45 cm above the floor
level. Entire room, except the open field was kept dark
during the experiment. Each animal was placed in the cen-
tral square and observed for 5 min and the following
behaviours were recorded. Ambulation – the number of
grid lines it crossed with all the four paws; rearing – by
counting the number of times the animal stood on its
hind limbs; grooming-number of times the animal made
these responses viz. grooming of the face, licking/cleaning
and scratching the various parts of the body, defecation –
the number of fecal boli excreted during the period and
immobility period. Between tests, the apparatus was
cleaned with 5% alcohol.
Behavioural despair test
Behaviour despair model used by Porsolt et al., 1978 was
followed to test antidepressant activity [21]. Rats were
forced to swim individually in a glass jar (45 × 12 × 45
cm3) containing fresh water of height 35 cm and main-
tained at 25 ± 3°C. After an initial 2–3 min period of vig-
orous activity, each animal assumed a typical immobile
posture. A rat was considered to be immobile when it
remained floating in the water without struggling, making
only minimum movements of its limbs necessary to keep
its head above water. The total duration of immobility
was recorded during the next 4 min of a total 6 min test.
Rats were then allowed to dry in a pre-warmed enclosure
(~32°C) before being returned to their home cage. All the
behavioural experiments were carried out between 0900–
1400 h.
Blood and organs collection
Twenty four hours after the last stress administration the
blood was collected from overnight fasted rats through
retro orbital puncture for biochemical analysis. Plasma
was separated by centrifuging the blood at 4000 rpm for
10 min. Plasma glucose and total lipids were estimated
using diagnostic kits immediately (Ecoline, Merck, India).
During conditions of stress, kidney synthesizes ascorbic
acid to compensate glutathione loss. Hence, the endog-
enous antioxidants such as SOD, CAT; non-enzymic anti-
oxidant – ascorbic acid and TBARS levels in were studied
in brain, kidneys and adrenals. On 23rd day rats were sac-
rificed and organs were isolated, weighed and homoge-
nized immediately with ice cold 10% KCl. The
supernatant was separated by centrifugation at 5000 rpm
for 10 min and stored at -80°C until the assay was done.
Superoxide dismutase (SOD)
SOD estimation was performed based on its ability to
spontaneously inhibit oxidation of adrenaline to adreno-
chrome [22]. 2.78 ml of sodium carbonate buffer (0.05
mM; pH 10.2), 100 µl of EDTA (1.0 mM) and 20 µl of the
supernatant or sucrose (blank) were incubated at 30°C
for 45 min. Thereafter, the reaction was initiated by add-
ing 100 µl of adrenaline solution (9.0 mM). The change
in the absorbance was recorded at 480 nm for 8 min.
Throughout the assay procedure temperature was main-
tained at 30°C. One unit of SOD produced approximately
50% of auto-oxidation of adrenaline. Results were
expressed as Units/mg protein.
Catalase (CAT)
CAT measurement was done based on its ability to
decompose hydrogen peroxide (H2O2) [23]. Briefly, 2.25
ml of potassium phosphate buffer (65 mM, pH 7.8) and
100 µl of the supernatant or sucrose (0.32 M) were incu-
bated at 25°C for 30 min. H2O2 (7.5 mM; 650 µl) was
added to initiate the reaction. The change in absorbance
was measured for 3 min at 240 nm and the results were
expressed as U/mg protein.
Ascorbic acid
Ascorbic acid was estimated by spectroscopy method [24].
One ml of 4% trichloroacetic acid was added to 250 µl of
supernatant. This mixture was kept at 4°C for 1 h and cen-
trifuged at 4000 rpm for 10 min. A 0.5 ml aliquot of the
supernatant was taken and 125 µl of dinitrophenyl hydra-
zine was added. This mixture was heated in water bath at
85°C for 30 min. Then 875 µl of 65% sulphuric acid was
Schematic diagram representing the study design Figure 1
Schematic diagram representing the study design.
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added slowly under ice cold water. After complete mixing,
the tubes were allowed to stand for 30 min at room tem-
perature, and the OD was read at 540 nm. The calibration
curve was prepared by using ultrapure ascorbic acid as
standard (1 mg/ml in sodium acetate buffer). The blank
and the standard solution were processed similarly. The
ascorbic acid levels were expressed as µg/mg of adrenals.
Lipid peroxide
The lipid peroxidation in terms of thiobarbituric acid
reactive substances (TBARS) was measured using the
method of Ohkawa et al., (1979) [25]. Mixture of 500 µl
of the supernatant, 200 µl of 8% sodium dodecyl sul-
phate, 1.5 ml of 20% acetic acid solution, 1.5 ml of 0.9%
aqueous solution of thiobarbituric acid and 1.3 ml of dis-
tilled water were heated in boiling water bath for 30 min.
After cooling, the red chromogen was extracted into 5 ml
mixture of n-butanol and pyridine (15:1v/v). The organic
layer was separated and the absorbance was measured at
532 nm. Lipid peroxide content was expressed as nmole
of malondialdehyde (MDA)/mg tissue. The calibration
curve was prepared by using 1, 1, 3, 3-tetra ethoxypropane
(TEP) as standard.
Protein estimation
Protein content of the samples was estimated by the
method of Lowry et al., using bovine serum albumin as
standard [26].
Statistical analysis
Results were expressed as mean ± SE. Data were analyzed
by one-way ANOVA followed by Dunnet's multiple com-
parisons using GraphPad Prism 4.0, statistics software. In
all the tests, the criterion for statistical significance was p
< 0.05.
Results
Phenolic content
Total phenolic content of 60% methanolic extract of CS
was found to be 8.54 ± 0.16 %w/w.
Body weight
Body weight of experimental animals was measured on
day 1 and 22 of the CMS period. The 21 days exposure to
CMS significantly decreased the body weight (4%)
[F(4,25) = 2.170, p < 0.05] in comparison to the control
group (37%). Treatment with CS 125 (17%) and 250 mg/
kg (15%)or DZM (31%) augmented the weight increase
of the rats however did not reverse completely the weight
change induced by CMS (Table 1). Gross pathological
examination of the CMS rats revealed, the presence of gas-
tric ulcer (+++). Treatment with CS 125 mg/kg (++) and
250 mg/kg (++) decreased the ulcer score. Similar findings
were observed with DZM treated group (+). The results
indicated the protective ability of these drugs against CMS
induced ulceration. Gastric ulcer scoring was performed as
described earlier by Sanyal et al (1982) [27].
Plasma biochemistry
In comparison to the control rats a significant [F(4,25) =
16.50, p < 0.05] increase in fasting blood glucose and total
lipid levels was observed in CMS group. CS controlled the
glucose and total lipid alterations significantly [F(4,25) =
24.42, p < 0.01] and the results were comparable with that
of the reference drug DZM (Table 1).
Behaviour analysis
Open field exploratory behaviour test
CMS rats exhibited anxious behaviour as evidenced by
decreased ambulation [F(4,25) = 6.108, p < 0.05], rearing
[F(4,25) = 6.729, p < 0.01], increased grooming [F(4,25)
= 7.739, p < 0.01] and immobility period [F(4,25) =
56.49, p < 0.01] in comparison to control rats. Treatment
with CS significantly reversed the stress induced behav-
ioural alteration in a dose dependent manner as observed
by increased ambulation, rearing and decreased immobil-
ity period as compared to the CMS group. Results were
comparable with that of the reference drug DZM. In the
open field exploration the CMS rats evinced significant
decrease in the central activity in comparison to control
rats. DZM increased the central activity in comparison to
CMS group. Though the CS treated rats exhibited an
increase in central action it was not significant (Table 2).
Table 1: Effect of CS on body weight, glucose and total lipids level in stressed rats
Groups Body weight (g) Glucose (mg/dl) Total lipids (mg/dl)
Day 1 Day 22
Control 167.0 ± 10.7 226.2 ± 14.3 77.5 ± 3.8 693.33 ± 24.9
CMS (0.3%CMC, 1 ml/kg) 169.2 ± 9.8 176.7 ± 8.43* 132.5 ± 11.3** 930.33 ± 33.0**
CMS+DZM (2 mg/kg, p.o) 170.8 ± 10.7 215.5 ± 15.5 55.50 ± 7.2†† 715.52 ± 29.1††
CMS+CS (125 mg/kg, p.o) 165.5 ± 11.3 197.3 ± 12.7 83.69 ± 4.6†† 583.90 ± 10.6††
CMS+CS (250 mg/kg, p.o) 171.3 ± 11.4 199.7 ± 12.1 61.75 ± 8.0†† 619.08 ± 32.7††
Data are expressed as mean ± SEM. * and † indicates statistical significance in comparison to control and stress groups respectively and denotes *, 
† p < 0.05 and **, † † p < 0.01BMC Complementary and Alternative Medicine 2008, 8:15 http://www.biomedcentral.com/1472-6882/8/15
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Behavioural despair test
Results of the behavioural despair test are represented in
Table 2. A significant [F(4,25) = 12.83, p < 0.05] increase
in immobility period was observed in CMS group in com-
parison to control rats indicating the presence of depres-
sion in the former group. Treatment with diazepam
significantly (p < 0.01) attenuated the stress induced
depression as recorded by decreased immobility period
whereas CS failed to alter the stress induced depressive
behaviour.
Antioxidant evaluation
Superoxide dismutase
Application of different stressors for 21 days significantly
depleted SOD activity in brain [F(4,25) = 110.9, p < 0.05],
kidneys [F(4,25) = 10.69, p < 0.05] and adrenals [F(4,25)
= 4.743, p < 0.05] of CMS rats. CS (125 and 250 mg/kg),
significantly improved the SOD activity in all the tissues
in a dose dependent manner. Diazepam improved the
SOD level only in kidney tissue but failed to show protec-
tion in adrenals and brain (Table 3).
Catalase
In comparison to control rats a significant decrease in the
CAT activity was observed in kidney [F(4,25) = 10.29, p <
0.05] and adrenals [F(4,25) = 18.95, p < 0.05] of CMS
rats. But brain CAT level remains unaltered. CS did not
demonstrate any significant increase in brain CAT level. It
produced a significant (p < 0.01) increase in CAT level in
kidneys at both doses. The CAT level in adrenals was
found to increase significantly (p < 0.01) only in the
group treated with 250 mg/kg of CS (Table 3). DZM recov-
ered CAT activity significantly in adrenals and failed to
produce any such effect in brain and kidney.
Ascorbic acid
Significant [F(4,25) = 5.222, p < 0.05] elevation in ascor-
bic acid levels were observed in the adrenals of CMS rats.
No alteration in kidney and brain ascorbic acid level was
observed. Treatment with CS during stress period signifi-
cantly decreased the adrenal ascorbic acid levels. However
the ascorbic acid levels in kidneys and brain did not show
any significant observation with CS treatment (Table 3).
DZM decreased ascorbic acid level in adrenal tissues of
CMS rats but no marked effect was noted in brain and kid-
neys.
Thiobarbituric acid reactive substances
Significant elevation of TBARS content in brain [F(4,25) =
9.567, p < 0.01], kidney [F(4,25) = 6.41, p < 0.01] and
adrenals [F(4,25) = 11.54, p < 0.01] was observed in CMS
rats in comparison to control rats. Administration of DZM
controlled this elevation significantly (p < 0.05) in all the
tissues studied. High dose of CS significantly decreased
the TBARS content in kidneys and adrenal tissues but not
in brain tissue (Table 3).
Discussion
Long-term exposure to multiple stressors can cause
depression in humans. Induction of depression using
CMS is considered as the most congruent animal model of
depressive conditions observed in humans after long term
exposure to multiple stressors [28]. CMS is a well-vali-
dated model, which has predictive, constructive and face
validity [29]. The results of the current study demon-
strated decreased body weight along with elevated blood
glucose and total lipid levels in rats exposed to CMS,
which are reminiscent of the features of subgroups of clin-
ically depressed patients [30,31]. The results were found
to be consistent with the report of glucose intolerance in
rats subjected to CMS [15]. The Brain-Pancreas Relative
Protein (BPRP) was reported to induce depression and its
loss resulted in decrease blood level of insulin leading to
increase blood glucose level in CMS model [32]. Admin-
istration of CS during stress period reversed the metabolic
changes indicating certain influence on neuro-endocrino-
logical system.
Open field exploratory test is commonly used to assess
locomotor, exploratory and anxiety-like behaviour in
Table 2: Effect of CS on open field exploratory test and behavioural despair test in CMS rats
Open field exploratory test Behavioural 
despair test
Groups Total Ambulation 
Central
Ratio Rearing Grooming Immobility 
period (sec)
Immobility 
period (sec)
Control 75.8 ± 3.6 11.5 ± 0.44 0.1575 22.33 ± 4.10 6.67 ± 1.09 48.16 ± 4.2 72.33 ± 7.1
CMS (0.3% CMC 1 ml/kg) 51.7 ± 2.5** 3.83 ± 0.42* 0.0740 8.83 ± 1.63** 11.5 ± 0.96** 197.83 ± 15.03** 126.33 ± 11.2**
CMS+DZM (2 mg/kg) 68.3 ± 3.78† 9.17 ± 0.27† 0.1341 14.00 ± 2.1 4.2 ± 0.9†† 36.00 ± 4.69†† 56.17 ± 6.1††
CMS+CS (125 mg/kg) 71.8 ± 6.5† 8.33 ± 2.06 0.1160 15.5 ± 1.69 7.5 ± 0.76† 79.5 ± 9.9†† 123.3 ± 10.7
CMS+CS (250 mg/kg) 80.0 ± 4.6†† 7.33 ± 2.16 0.0916 23.83 ± 1.30†† 6.33 ± 1.06†† 49.0 ± 5.45†† 120.16 ± 9.7
Data are expressed as mean ± SEM. * and † indicates statistical significance in comparison to control and stress groups respectively and denotes *, 
† p < 0.05 and **, † † p < 0.01BMC Complementary and Alternative Medicine 2008, 8:15 http://www.biomedcentral.com/1472-6882/8/15
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experimental animals (rats/mice). In the open field test,
CMS rats exhibited decreased ambulation and rearing
which indicated reduced exploration and apathy respec-
tively in these animals. Increased immobility period and
grooming activity depicted a higher level of anxiety [15].
Treatment with CS reversed the altered open field behav-
iour significantly and this probably is due to its anxiolytic
effect. Behavioural despair test is used to measure the anti-
depressant effect of drugs. CMS rats exhibited depression
evidenced by increased immobility period in behavioural
despair test. Administration of CS failed to show any effect
on the immobility period in CMS rats. The results indi-
cated that CS possesses anxiolytic activity but no antide-
pressant activity. The standard drug diazepam controlled
the metabolic alterations and gastric ulcers in CMS rats
indicate the GABAergic role in CMS induced physiological
alterations. Earlier reports indicated that diazepam
reversed the stress induced non-grooming and grooming
behaviour and gastric ulcers in rats [33,34] which sup-
ports our present findings. Further, diazepam reversed the
CMS induced behavioural alterations and showed anxio-
lytic activity in open field test, antidepressant activity in
behavioural despair test. This effect of diazepam may be
attributed to its anti stress property. Hence, it can be spec-
ulated that CS might exert similar activity on GABAergic
system rather than the adrenergic or serotonergic system
former plays a vital role in anxiolytic property.
Antioxidant study in different tissues of CMS rats revealed
decreased SOD, CAT levels and increased TBARS levels
denoting that administration of different stressors trig-
gered free radicals generation. Further, adrenal ascorbic
acid level was found to be elevated in stressed rats which
clearly denoted that CMS rats were under oxidative stress
and the biological system exhibits an adaptive mecha-
nism. In stressed conditions similar metabolic alterations
were reported resulting in the imbalance of energy utiliza-
tion and consequently in the generation of superoxide
anion, hydrogen peroxide and hydroxyl radical ions as the
major reactive oxygen species (ROS) in the bio-systems
which provoked cell lipid membrane peroxidation. Lipid
peroxide products reportedly caused widespread cellular
injury [35]. Endogenous enzymic antioxidants such as
SOD, which dismutases the highly reactive superoxide
anion to the less reactive species H2O2 [36], CAT, a haeme
containing enzyme, which scavenges hydrogen peroxide
to water and molecular oxygen [37] and non-enzymic
ascorbic acid, which is a water-soluble antioxidant forage
free radical protect the biological system from oxidative
stress [38].
Treatment with CS decreases the CMS-induced SOD and
CAT alterations. Further, CS treatment led to decreased
TBARs content in different tissues, resulting in attenuation
of the adverse effects of chronic stress due to generation of
Table 3: Effect of CS on endogenous antioxidant and TBARS level in CMS rats
Groups
Parameters Control CMS CMS+DZM (2 mg/kg, p.o) CMS+CS
125 mg/kg, p.o 250 mg/kg, p.o
SOD (U/mg protein)
Brain 1.09 ± 0.03 0.21 ± 0.02** 0.98 ± 0.04†† 1.30 ± 0.07†† 1.54 ± 0.06††
Kidneys 0.75 ± 0.03 0.51 ± 0.05** 0.66 ± 0.05 0.71 ± 0.05†† 0.88 ± 0.01††
Adrenals 0.99 ± 0.10 0.56 ± 0.04** 0.85 ± 0.07† 0.92 ± 0.09† 0.83 ± 0.06
CAT (U/mg protein)
Brain 1.77 ± 0.13 1.67 ± 0.28 1.50 ± 0.36 2.13 ± 0.41 2.63 ± 0.56
Kidneys 2.87 ± 0.35 1.43 ± 0.37* 1.83 ± 0.40 3.14 ± 0.24†† 3.93 ± 0.14††
Adrenals 1.27 ± 0.15 0.25 ± 0.02** 0.8 ± 0.06†† 0.41 ± 0.08 0.72 ± 0.09††
Ascorbic acid (µg/mg protein)
Brain 13.75 ± 3.50 14.25 ± 3.50 12.50 ± 3.13 10.38 ± 2.63 12.25 ± 3.13
Kidneys 17.83 ± 2.00 23.33 ± 1.67* 18.33 ± 1.50 20.50 ± 1.17 18.33 ± 0.67
Adrenals 43.33 ± 4.7 90.00 ± 11.33** 49.67 ± 6.53†† 58.67 ± 9.13† 68.67 ± 6.67
TBARS (nmol of MDA/mg tissue)
Brain 0.15 ± 0.02 0.89 ± 0.12** 0.42 ± 0.10†† 0.48 ± 0.07†† 0.38 ± 0.09††
Kidneys 0.19 ± 0.02 0.84 ± 0.07** 0.53 ± 0.05 0.58 ± 0.04 0.38 ± 0.19††
Adrenals 0.28 ± 0.24 1.23 ± 0.13** 1.04 ± 0.21† 1.32 ± 0.28 1.09 ± 0.33†
Data are expressed as mean ± SEM. * and † indicates statistical significance in comparison to control and stress groups respectively and denotes *, † 
p < 0.05 and **, † † p < 0.01BMC Complementary and Alternative Medicine 2008, 8:15 http://www.biomedcentral.com/1472-6882/8/15
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ROS. The phenolic content of CS was found to be 8.54%
which may contribute to the observed antioxidant effect.
The active principles flavone 6"-O acetyl scoparin [10],
flavonals, namely, rutin, quercetin, quercitrin, iso rham-
netin and kaempferol [11] and isoflavones like genistein
and sarothamnoside [12] might have contributed to the
antioxidant property of the herb. Earlier reports demon-
strated that herbs containing flavonoids, tannins and phe-
nolic compounds were found to possess antioxidant
property and attenuate cell death induced by oxidative
stress [39,40] which supported our present findings.
Results of the present study indicate that the anti-stress
activity of CS may be due to its antioxidant potential.
Conclusion
To conclude, CS showed moderate anxiolytic activity and
high propensity to improve the antioxidant status in CMS
rats. Hence, this antioxidant effect may be the cardinal
mechanism that is expressed as the adaptogenic activity of
CS. Further studies may elucidate the possibility of the
commercial use of CS for the benefit of patients suffering
from psychotic disorders.
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